SCHEMBL22041600

SCHEMBL22041600

O=C(Oc1c(Br)c(Br)cc2cc(C(=O)O)c(=O)oc12)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 15/20 0.52
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA3 P07451 2/20 0.43
▸ CA4 P22748 2/20 0.43
▸ CA6 P23280 2/20 0.43
▸ CA5A P35218 2/20 0.43
▸ CA7 P43166 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ CA5B Q9Y2D0 2/20 0.43
▸ CA2 P00918 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAOA P21397 2/20 0.41
▸ MAOB P27338 3/20 0.41
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041935 0.88 GPR35 (0.51) GPR35CA12CA1CA3CA4
SCHEMBL22041625 0.88 GPR35 (0.56) GPR35CA12CA1CA3CA4
SCHEMBL22041623 0.84 GPR35 (0.55) GPR35CA12CA1CA3CA4
SCHEMBL22041589 0.83 GPR35 (0.50) GPR35CA12CA1CA3CA4
SCHEMBL22041604 0.83 GPR35 (0.55) GPR35CA12CA1CA3CA4
SCHEMBL22041599 0.83 GPR35 (0.52) GPR35CA12CA1CA3CA4
SCHEMBL22041620 0.81 GPR35 (0.53) GPR35CA12CA1CA3CA4
SCHEMBL22041612 0.81 GPR35 (0.58) GPR35CA12CA1CA3CA4
SCHEMBL22041622 0.80 GPR35 (0.51) GPR35CA12CA1CA3CA4
SCHEMBL22041626 0.79 GPR35 (0.64) GPR35CA12CA1CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback